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ABSTRACT
Reproducibility of data from experimental investigations using animal
models is increasingly under scrutiny because of the potentially
negative impact of poor reproducibility on the translation of basic
research. Histopathology is a key tool in biomedical research, in
particular for the phenotyping of animal models to provide insights
into the pathobiology of diseases. Failure to disclose and share
crucial histopathological experimental details compromises the
validity of the review process and reliability of the conclusions. We
discuss factors that affect the interpretation and validation of
histopathology data in publications and the importance of making
these data accessible to promote replicability in research.
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Reproducibility: an age-old quest
“A good physiological experiment… requires that it should present
anywhere, at any time, under identical conditions, the same certain
and unequivocal phenomena that can always be confirmed.” –
Johannes PeterMüller, German physiologist and
comparative anatomist (1801-1858).
Illustrated by this quote from Müller, a formal concept of
reproducibility existed even in the beginnings of modern
experimental biology. Today, the ability to reproduce experimental
findings remains essential for the forward movement of science and
the application of laboratory findings to the clinic.
There has been much discussion in recent years about the
reported irreproducibility of preclinical data obtained using animal
models (Begley and Ioannidis, 2015; Collins and Tabak, 2014;
Freedman et al., 2015; Mak et al., 2014) and the cost to the success
of both translational research and the public purse. The inability to
replicate drug-target discovery studies and to reliably replicate
phenotype observations from the literature (Begley and Ellis, 2012)
has caused profound concern amongst investigators and funding
agencies alike, which has been mirrored in discussions and
commentaries in the literature. Several issues are tied up
inextricably in these discussions. Reproducibility depends first
and foremost on the accurate and comprehensive reporting of key
experimental procedures and conditions, but it also depends on the
open availability of the data, protocols and reagents (Schofield et al.,
2009). Both aspects of reproducibility are crucial, and require
distinct solutions.
These discussions have stimulated action on the part of funding
agencies and scholarly societies to improve the reliability and
reproducibility of animal-model-based research. For example, the
US National Institutes of Health (NIH) has recently introduced
guidelines on rigor and transparency for grant applications1, and the
Federation of American Societies for Experimental Biology
(FASEB) held a meeting in August of 2015 to help members
prepare to comply with these new requirements. Scientific journals
also have a crucial role in improving reproducibility; acting as
effective gatekeepers of knowledge. This depends on enforcement
of journal policies on reporting and transparency, and making data
sharing and openness part of the community norms that should be
expected by reviewers and authors. The ability of researchers to
replicate published studies depends on the quality of the peer review
process and insistence on full disclosure of data and methods.
Histopathology has been, and remains, a central approach to the
characterization of phenotypes of model organisms and humans
alike, and has a very important role in both high-throughput and
hypothesis-driven characterization of mouse mutants as models for
human diseases and therapeutic endpoints (Adissu et al., 2014;
Schofield et al., 2012). Replicability of histopathological findings
has a major impact on the interpretation of the effects of a mutation
or drug treatment, yet the reporting of histopathology in many, if not
most, papers often lacks transparency and completeness. Moreover,
although scientific errors in pathology can largely be avoided by
careful planning and the use of expert, board-certified pathologists,
the ability to detect these errors in peer review depends on
comprehensive disclosure of the details of animals and protocols.
Recommendations on best practice in mouse experimentation were
recently discussed in an article from Justice and Dhillon (2016) and,
earlier this year, Scudamore and colleagues proposed a set of
minimal standards for the reporting of histopathological findings
in experimental pathology data (Scudamore et al., 2016).
The guidelines cover technical aspects of histopathology
comprehensively, such as the use of proper terminology and
declaration of the level of skill of the pathologist, but there are
additional parameters that affect the type, frequency and severity of
lesions, which cannot be assessed without full disclosure from
investigators. Of course, histopathology assessed by non-
pathologists, or those without specialized training in laboratory
mouse pathology, can often lead to lack of reproducibility due to
lack of expertise. Surprising though it may seem, basic information,
such as strain, mutated gene allele, age and sex of mice, is often
lacking or incorrect in study descriptions, and such omissions can
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have a profound effect on the reproducibility of histopathological
findings or even the validity of the interpretation. These issues are
compounded by the diverse effects of environment, microbiome,
diet and breeding history, as discussed below. As early as 1993,
variations in the phenotypes of non-obese diabetic (NOD) mice in
different laboratories were investigated using a questionnaire, which
demonstrated the impact of factors such as the source of the mice,
colony size, breeding, diet, specific-pathogen-free (SPF) status and
disease control (Pozzilli et al., 1993). Below, we explore those
factors that have been identified as important in the interpretation
of phenotypes in mouse experimental pathology, and identify
challenges in capturing and reporting them in the quest for enhanced
reproducibility.
Age, sex, strain, and allelic mutation: ASSAM
Mouse genetic nomenclature is a crucial part of the materials and
methods of any paper. This includes the strain designation as well as
any mutated genes under investigation. Not only should the gene be
listed and listed correctly, using the most current name and symbol
[refer to Mouse Genome Informatics (http://www.informatics.jax.
org/marker) and to Sundberg and Schofield (2009)], but the specific
allele as well. For example, although C57BL/6J and C57BL/6NJ
are very similar, the latter substrain is homozygous for retinal
degeneration 8 (Crb1rd8) (Mattapallil et al., 2012), which must be
corrected for ocular studies (Low et al., 2014). Therefore, simply
referring to C57BL/6 mice or B6 is inadequate, and without this
specification one might interpret background lesions as being due to
an experimental manipulation, especially if the background
phenotype is partially penetrant or varies in severity from mouse to
mouse. If the strain is incorrectly represented, or even omitted, then a
reviewer cannot assess the results. Increasing differences between 6N
and 6J are now coming to light (Simon et al., 2013) and it is important
that investigators use the appropriate substrain as control.
One issue not often discussed, persisting like an elephant in the
sitting room, is the existence of ‘passenger’ variants or mutations
that remain close to a manipulated target gene during congenic
crosses (Vanden Berghe, et al., 2015). Although it is often assumed
that ten crosses onto a new background are sufficient to consider the
strain stably inbred, recent examples show that this might not always
be true, and passenger mutations have recently been found to
account for the defective IL-1β production of a Casp1-null
(Casp1tm1Sesh) mouse strain that was found to carry a null
passenger mutation in the neighboring Casp11 gene (Kayagaki
et al., 2011), the actual cause of the phenotype. Not knowing how
many crosses were undertaken onto a new background seriously
reduces the ability of reviewers to assess the likelihood of the impact
of passenger mutations on the phenotype; therefore, it is crucial that
this detail is always reported.
Similarly remarkable is the failure of many investigators to
specify the sex and age of their mice. All inbred strains are prone to
developing a variety of diseases spontaneously. In many cases the
frequency of these diseases increases with age and often has a sex
bias (Sundberg et al., 2011, 2016). These predispositions need to be
known by investigators in order to differentiate them from changes
associated with the mutation under investigation. A recent
comprehensive text-mining exercise of more than 15,000
experimental mouse papers (Flórez-Vargas et al., 2016) showed
that, although the percentage of papers reporting the sex and age of
mice has increased over the past 20 years, only about 50% of the
papers published in 2014 reported both of these traits. However, this
is marginally worse than when a similar study was conducted in
2009 (Kilkenny et al., 2009). The correct interpretation of
histopathological data, like many other types of phenotype data,
often depends on knowing both age and sex. Both of these criteria
are thus included in the ARRIVE guidelines (Animal Research:
Reporting of In Vivo Experiments), which were introduced with the
aim of improving standards in reporting of biological research
(Kilkenny et al., 2010). However, a recent estimate of compliance
with the guidelines suggested that there has been little improvement
since the guidelines were released in 2010 (Baker et al., 2014).
Although many journals include these criteria as a requirement for
publication in their instructions for authors, not all editors or
reviewers mandate compliance, often in efforts to save space. One
challenge in complying with the guidelines, highlighted by Karp
et al. (2015), is the availability of standardized language and data
structure in which experiments are formally described. The
integration of these formal standards into animal data
management tools and databases should help with both data
capture and encouragement of good practice. Nonetheless, a clear
statement by funding agencies and in journal editorial policies,
requiring that the ARRIVE guidelines be adhered to, will be a
crucial factor in improving the reporting of in vivo experiments
across the bioscience community; this will need to be matched by
the will to enforce the requirements.
Impact of the microbiome
The reporting of environment, health (pathogen) status and diet is
widely accepted to be important in behavioral and metabolic studies
(Nature Biotechnology Editorial, 2009; Reardon, 2016), and yet all
can have profound effects on the nature and severity of histological
lesions in experimental mice (Ward, 1997). The unprecedented
ability to analyze and characterize the microbiome using next-
generation sequencing (NGS) has brought about a revolution in our
appreciation of what used to be ‘known unknowns’ in factors
affecting animal phenotypes. We now know that there is a clear
genetic and environmental impact on the gut microbiome and that
this in turn can influence experimentally induced phenotypes
(Campbell et al., 2012), discussed in an excellent review by
Laukens et al. (2016). Factors such as housing, local animal house
microbiota and diet can all affect the mouse gut microbiome
(Nguyen et al., 2015). It was recently shown that even between the
C57BL/6N and C57BL/6J substrains, mice have differences in
intestinal microbiome (Newberry et al., 2015) and, across a whole
range of strains, individuals show much more intrastrain conformity
than between strains (Kovacs et al., 2011). Of concern is the
observation that mice of the same strain from different vendors have
different intestinal flora (Ericsson et al., 2015) and that gut flora
have been found to be significantly heritable through the maternal
line for several generations, suggesting that, optimally, only related
individuals should be used as experimental controls to reduce
microbiome variation.
Both the presence of individual pathogens or the specific gut or
skin microbiome has increasingly being shown to affect the
severity or type of mutant mouse phenotypes (reviewed by
Treuting et al., 2012; Barthold, 2004). There are many such
examples, often related to inflammatory or immune phenotypes;
for example, the presence of Helicobacter promotes tumors in the
colons of ApcMin or 129-Smad3tm/Par/J mice (Newman et al., 2001;
Maggio-Price et al., 2006) and the strain-specific colitis phenotype
of IL10-deficient mice depends on differences in microbiome
composition (Buchler et al., 2012). Remarkably, the spontaneous
colitis phenotype in mice lacking Tbx21, a regulator of the innate
immune response (Garrett et al., 2007), depends on the presence of
only 12 microbial species (Powell et al., 2012). There could also be
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sex-dependent effects of the microbiome; for instance, male-
specific differences in microbiome composition have been shown
to provide protection from type 1 diabetes in NOD mice (Markle
et al., 2013).
As part of reports attributing a specific phenotype to a particular
mutation or variant, information about the vendor, stock numbers
and dates of acquisition should be recorded, and there should be
meticulous documentation of details relating to backcrossing and
pedigree. Tied in with what we already know about variations of
phenotypes between even closely related substrains (Simon et al.,
2013), the additional impact of microbiome and health status needs
to be considered carefully, and at the very least relevant details
reported to allow a more complete assessment of the experimental
findings, especially findings that could have preclinical and
translational applications.
Impact of diet
The importance of diet is illustrated by studies involving mutations
that affect calcium metabolism. When mice that model ectopic
mineralization are placed on diets with increased phosphate and
reduced magnesium (‘acceleration diet’), the speed of development
and the distribution of lesions are changed (Li et al., 2014). For
example, epicardial mineralization and fibrosis are commonly
observed in old KK/HlJ mice on standard mouse diets (Berndt et al.,
2014) but, when the mice are placed on the ‘acceleration diet’,
mineralization and fibrosis becomes multifocal, involving the entire
myocardium and infrequently the epicardium alone (Quiaoli Li,
Jouni Uitto and J.P.S., unpublished data).
Much of our knowledge on the impact of diet on phenotypes
pertains to the effects of dietary fat on metabolism; however, non-
metabolic phenotypes could also be affected. For example, a high-
fat diet greatly exacerbates the cardiac development phenotype of
Cited2 loss-of-function mutants (Cited2tm1Bha) (Bentham et al.,
2010). Long-term exposure to diets supplemented with methyl
donors, including betaine, methionine and folate, induce wide-
ranging heritable and reproducible changes in epigenetic markers.
The affected genes include those in pathways controlling gene
expression and embryonic development (Li et al., 2011). Moreover,
small changes in dietary composition affect placental development
and histological remodeling, which have been suggested to
influence the intrauterine programming of life expectancy (Coan
et al., 2011).
Commercial ‘standard chow’ diets vary substantially depending
on the producer. The total fat content can vary between 3.5 and
12%, and the type of fat can also vary, with animal fat or soy oil used
in different formulations, together with different levels of vitamin E,
other anti-oxidants and phytoestrogens (Reliene and Schiestl,
2006). In a survey on the composition of diets reported as being
‘high fat’, Warden and Fisler (2008) reported that only 5 out of the
35 papers they examined that claimed to use animal models of high-
fat feeding had actually compared two diets differing only in the
relative amounts of fat and carbohydrate, and 34% had insufficient
data on diet to allow the studies to be reproduced.
It is clear, therefore, that, in many cases, replication of
experiments could be confounded by a lack of information about
the experimental diet used. Diet could affect the pathobiology of
mutants directly or indirectly through effects, for example, on the
microbiome of the gut as discussed above (Nguyen et al., 2015) or
even through changes in behaviour (Pyndt Jorgensen et al., 2014).
The possibility that some investigators might not know how their
animals are being fed raises serious concerns for interpretation of
data as well as its reproducibility.
Above, we have discussed only some of the factors that influence
the nature of lesions, particularly inflammatory and neoplastic, that
can be detected through histopathology. Although appreciation of
the potential confounding nature of some of these environmental
factors on interpretation of pathological findings is important, this
is not a plea for experimental standardization. It has become clear
that heterogeneity of environment might be very important in
improving mouse models of human diseases precisely because
environmental parameters are not standardized across all animal
facilities, mirroring the diversity of environments in which humans
live (Richter et al., 2009; Reardon, 2016; Beura et al., 2016). What it
does highlight though, is the importance of the capture and
presentation of these parameters in publications. As yet, they are not
covered in detail by the ARRIVE guidelines and it might now be
time to consider increasing the granularity of the guidelines, within
the scope of what is reasonable, as balanced against what might
significantly affect the interpretation of results.
An image problem
The primary data behind histopathological findings are almost always
photo- or electron micrographs and, as discussed in Scudamore et al.
(2016), the space for publishing selected images in papers is often
limited or restricted. In some cases, images are not published at all but,
more often, small ‘representative’ images are made available. Again,
this makes it very difficult to assess the quality of the study and the
validity of the interpretation. This size limitation thus presents an
obstacle to reader interpretation of published data, but, in addition, the
lackof rawphotomicrographs in submittedmanuscriptsmakes it an act
of faith for a reviewer tomake a judgment on a study during the review
process. Furthermore, most manuscript reviews of studies using
mousemodels still do not include assessment byexperienced qualified
pathologists. Mandated sharing of primary data is now becoming
standard for many funding agencies2, and deposition of primary data
in suitable repositories has become a condition of publication in many
journals. However, with the exception of supplementary information
sections in journals, there are no dedicated platforms for the sharing of
many kinds of data, and most publicly available repositories are for
specific types of data, e.g. microarray gene expression datasets. To
date, there has been no large-scale commitment of major funding
agencies to provide platforms for the provision of experimental
pathology data (specifically, whole-slide images).
Pathbase (www.pathbase.net) is an example of a community
resource that provides a platform for sharing images for mouse
histopathology (Schofield et al., 2010), and the Mouse Tumor
Biology (MTB) database (Bult et al., 2015) for images of neoplastic
and hyperplastic lesions. Both are community resources – copyright
remains with submitters – and both have been running for more than
15 years. Pathbase uses standard anatomical and pathological
ontologies for metadata. There are also web services provided for
computational access and, recently, the database has been moved
onto the OMERO open source platform. Pathbase and the MTB
database are both heavily accessed and open to user submission, but
the number of images uploaded directly from the community as
opposed to from targeted studies remains disappointingly low. An
ongoing challenge for both databases is lack of external funding
and, considering various sustainability models, it is clear that it
would be difficult to maintain a long-term community role without
external funding input. There are currently no established large-
2The Biosharing website, https://biosharing.org/, contains policy summaries for
major funding agencies.
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scale databases of histopathology, apart from MTB and Pathbase,
that allow data uploading for free, allow users to retain rights over
images and provide free access to all users. More recently, The
Company of Biologists (publisher of Disease Models &
Mechanisms) and other publishers have partnered with Dryad, a
curated resource for the deposition of different types of data, to
facilitate data sharing for all publication-associated data. Although
this could help in addressing the wider issue of irreproducibility, as
yet Dryad cannot accept whole-slide histopathology images and so
the problem of making these data generally accessible through
public, as opposed to local lab, resources remains highly important.
The ‘image problem’ thus remains an issue for the sharing of
histopathology data and, given the scale of the problem, a
substantial and collaborative commitment from funding agencies
and publishers is needed in order to ensure that data are accessible so
that the accuracy, accountability and reproducibility of results can be
verified.
Concluding remarks
In the first instance, reproducibility depends on informed expert
review, which, like replication, depends on the disclosure and public
sharing of primary data and comprehensive protocols. Qualified and
experienced histopathologists are needed as part of the review
process in cases where histopathology data is the main evidence for
phenotypes. The absence of a platform for sharing such images,
with appropriate discoverability, remains a problem that journals
and funding agencies alike need to address in terms of funding
support and increased awareness.
The impacts of strain, sex, age and allele, together with
environmental factors, such as housing, diet, health status and
microbiology, are highly significant and can radically change the
interpretation of histopathology data. There needs to be increased
awareness of these factors within the community but, as importantly,
these parameters need to be captured and sharedwith publications. The
ARRIVEguidelines cover all of the parameters identified here in detail
and yet there is still a problem in persuading authors to provide this
information and for journals to enforce their own policies. Inclusion of
ARRIVE parameters in Laboratory InformationManagement System
(LIMS) software might encourage reporting, as suggested by Karp
et al. (2015), but an interesting possibility is for institutional animal
facilities to publish overall husbandry conditions on their websites, or
make an updated document available to referees and readers in which
at least some of the key parameters, such as the source of standard
chow, water treatment, light/dark cycles, SPF status and definition
might be obtained. This is currently done for the scientists at The
Jackson Laboratory because many of their research colonies are the
primary source for mutants that are distributed to the community. The
production of standard animal facility husbandry and disease status
reports, put together bymanagers and supervising veterinarians,might
addressmanyof these issues efficiently. Thiswould leave investigators
only with the need to flag deviations from standard facility conditions
in their experiments.
The bottom line, however, is that it is only with a firm
commitment to disclosure and sharing by investigators, journals
and funding agencies, and a recognition by the latter that, in many
cases, ensuring reproducibility has a financial cost, that we will see
better value for money from investment in model organism
development and, in turn, a more robust translational pipeline.
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